|Day Low/High||32.66 / 35.13|
|52 Wk Low/High||16.69 / 41.57|
Trade-Ideas LLC identified Medicines Company (MDCO) as a new lifetime high candidate
Researchers at ESC Congress 2015 presented data from secondary analyses of the CHAMPION PHOENIX trial comparing cangrelor, The Medicines Company's fast-acting, rapid offset, intravenous antiplatelet agent, to oral...
The stock markets in the United States declined today with the S&P 500 heading towards its worst month in more than three years. The index dropped 0.84% to 1,972.07 points today. The S&P 500 d...
Here's a technical look at some of the most active stocks on the market today.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Medicines (MDCO) stock is soaring on Monday after the drug maker along with Alnylam Pharmaceuticals (ALNY) announced positive results of a new cholesterol drug.
Trade-Ideas LLC identified Medicines Company (MDCO) as a pre-market mover with heavy volume candidate
The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has named Dr.
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, and The Medicines Company (Nasdaq:MDCO), a global biopharmaceutical company focusing on saving lives, alleviating suffering and...
Here are Friday's top research calls, including downgrades for Borg Warner and United States Steel and an upgrade for Akamai Technologies.
The Medicines Company today announced it will present results of recent clinical studies from its cardiovascular product portfolio at the 2015 European Society of Cardiology (ESC) Congress in London, August 29 to September...
The Medicines Co. (MDCO) price target was increased to $40 from $35 at Leerink, which reiterated its 'outperform' rating.
Trade-Ideas LLC identified Medicines Company (MDCO) as a weak on high relative volume candidate
The Medicines Company (NASDAQ:MDCO) today announced its financial results for the second quarter and first half of 2015.
The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call for Wednesday, July 29 th at 8:30 a.
The Medicines Company (NASDAQ:MDCO) today announced an agreement with Sandoz Inc.
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Trade-Ideas LLC identified Medicines Company (MDCO) as a strong on high relative volume candidate
Medicines & Co. (MDCO) shares have been gaining all day before a court ruling on its patent infringement claims against Hospira (HSP).
The Medicines Company (NASDAQ:MDCO) announced the U.S.
Trade-Ideas LLC identified Medicines Company (MDCO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
The Medicines Company (NASDAQ:MDCO) today announced the approval of KENGREAL™ (cangrelor) by the U.
Stocks with insider trader activity include CLCT, MDCO and LQ
The Medicines Company (NASDAQ: MDCO) has scheduled a conference call on June 2 at 8:30am EST to discuss results of first phase clinical studies for the investigational anesthetic agent, ABP-700, and the investigational...
The Medicines Company (NASDAQ:MDCO) announced Phase 1 results for ABP-700, a novel, positive allosteric modulator of the GABA A receptor currently being developed for general anesthesia and procedural sedation.
The Medicines Company (NASDAQ:MDCO) presented the results of a Phase 1 study for MDCO-216 that showed that the drug had a significant remodeling effect on HDL particles, which correlated with increased ABCA1-mediated...
The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Jefferies 2015 Healthcare Conference in New York, NY on Monday, June 1, 2015 at 10:00 AM EDT.
Investors in Medicines Co saw new options become available this week, for the January 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, NV on Thursday, May 14, 2015 at 10:00 AM PT.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.